Risk factor
Resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Neogen Chemicals Limited, founded in Thane, India, in 1989, is engaged in the manufacturing and supply of an extensive array of specialized chemical products. The company's comprehensive portfolio encompasses numerous organo-bromine compounds, including alkyl bromides, dibromoalkanes, bromo chloro alkanes, various bromine derivatives (of organoacids, esters, aromatics, and cyclics), and specialty bromo-fluoro derivatives. Additionally, Neogen offers specialty chloro compounds, unsaturated and bromo-hydroxy derivatives, inorganic bromine compounds, lithium salts, Grignard reagents, and advanced intermediates. Beyond its product range, the firm also provides custom synthesis and contract manufacturing services. Neogen's offerings cater to diverse industrial sectors such as pharmaceuticals, agrochemicals, engineering, flavors and fragrances, electronic chemicals, refrigeration, construction, specialty polymers, and heating, ventilation, and air conditioning (HVAC). The company maintains an international presence, exporting its chemicals to 28 nations globally.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of NEOGEN.NS is 1943 and suggests 9.79% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation